Skip to main content

Table 1 Secondary endpoints

From: Ventricular tachycardia ablation guided or aided by scar characterization with cardiac magnetic resonance: rationale and design of VOYAGE study

Secondary endpoints
Health-related quality of life changes
Procedural time (introducer in-introducer out)
Fluoroscopy duration
X-ray exposure
Radiofrequency time
Number of RF applications
VT inducibility at the end of ablation with number of residual VTs
Appropriate and inappropriate ICD interventions (ATP or shocks) anytime and after 1 month
Rate of patients with contraindication to CRM or with poor CMR imaging
Hospital admission for cardiac causes
VT storm anytime and after 1 month
Composite endpoint including death at any time, VT storm and appropriate ICD shock after 1 month of treatment
Complications during 12-month follow-up
Death (related or not to the procedure)
Myocardial infarction
Stroke or transient ischemic attack (TIA)
Other thromboembolic events
Cardiac perforation or tamponade
Vascular complications
Prolonged or repeat hospitalization
Heart block
Pericarditis requiring intervention
Pulmonary edema
Hepatic injury
Abdominal issues